Survival curve analyses (gepia.cancer-pku.cn) revealed patients with higher METTL3 mRNA levels exhibited much shorter relapse-free survival rate (Figure 1K)22; however, no significant correlation between METTL14, FTO, or ALKBH5 expression and survival rate was observed (Figure 1L-N). This evidence concerns the gene ALKBH5 and cancer.